Erythropoietin (EPO) vs Semax
Extensively Studied vs Well Studied
monitor Mechanism-based · 51% Both Erythropoietin (EPO) and Semax can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar).
Molecular Data
Erythropoietin (EPO) Semax
Weight 30,400 Da 813.93 Da
Half-life 4-12 hours (IV), ~25 hours (SubQ) 0.5-2 hours
Chain 165 amino acids 7 amino acids
Type Glycoprotein hormone ACTH(4-10) synthetic analog
Key Benefits
Erythropoietin (EPO)
01 Stimulates red blood cell production
02 Increases oxygen-carrying capacity
03 FDA-approved for anemia treatment
04 Improves endurance capacity
05 Supports patients with chronic kidney disease
06 Helps chemotherapy-induced anemia
07 Well-characterized mechanism of action
08 Extensively studied safety profile
Semax
01 Rapid brain delivery via intranasal route
02 Rapidly increases BDNF levels
03 Extensive clinical research in Russia
04 Easy self-administration
05 Modulates dopamine and serotonin systems
06 Neuroprotective effects
Dosing Protocols
Erythropoietin (EPO)
50-300 IU/kg based on medical indication / 1-3 times weekly depending on response
CKD Anemia (medical) 50-100 IU/kg 3x weekly
Chemotherapy Anemia (medical) 150-300 IU/kg 3x weekly
Maintenance (medical) Individualized 1-3x weekly
Semax
300-600mcg per dose (up to 1000mcg for intensive use) / 1-2x daily (morning recommended for cognitive boost)
Research protocol 500-750mcg 1x daily
Intensive protocol 750-1000mcg 1-2x daily
Side Effects
Erythropoietin (EPO)
Injection site reactions
Headache
Hypertension
Joint pain
Flu-like symptoms
Semax
Mild nasal discomfort (nasal route)
Possible nasal sensation upon administration
Contraindications
Uncontrolled hypertension
Pure red cell aplasia history
Hemoglobin >12 g/dL (increased cardiovascular risk)
Active malignancy (relative contraindication)
Pregnancy or breastfeeding
Known peptide allergies
Do not exceed 4-week continuous use without medical supervision
Research Evidence
Erythropoietin (EPO) Semax
Status Extensively Studied Well Studied
References 4 studies 5 studies
Latest — 2025
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.